Multivariate analysis confirmed the independent prognostic value of PD-L1 positivity, resulting in decreased time to castration resistance (p = 0.002) also in patients with low-volume metastatic disease (p = 0.005). This evidence concerns the gene CD274 and metastatic neoplasm.